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Abstract
Background: An extrapulmonary small cell carcinoma is a rare condition. It has similar histological
features to pulmonary small cell carcinoma and is equally aggressive.
Case presentation: We present the case of a 60-year-old woman who presented with right
upper quadrant pain. Computerised tomography revealed an appendiceal lesion and multiple liver
metastases. Exploratory laparotomy and right hemicolectomy was performed with
histopathological analysis confirming a primary small cell carcinoma of her appendix.
Conclusion: This is the first reported case of a pure extrapulmonary carcinoma arising from the
appendix.
Background
Extrapulmonary small cell carcinomas (ESC) are rare.
Many different sites of origin have been described includ-
ing kidney, bladder, prostate, endometrium, salivary
glands, nasal sinuses and intestinal tract [1-5]. Primary
colonic ESC remains the rarest and most aggressive. There
is an equal sex distribution with a preponderance for mid-
dle aged patients. We present a case of a 60-year old
female with a primary small cell carcinoma of the appen-
dix with liver metastasis.
Case presentation
A 60-year-old female was admitted with a 4-day history of
right upper quadrant pain. She was treated with oral anti-
biotics for suspected acute cholecystitis. She had a past
medical history of Type-2 diabetes and hypertension. She
was a non-smoker. The patient had no fever, sweating or
rigors but described similar intermittent pain with associ-
ated nausea and vomiting over the preceding 6-weeks. On
examination, the patient was comfortable and well nour-
ished. Her clinical parameters (pulse and blood pressure)
were normal and she was apyrexic. Abdominal examina-
tion revealed right upper quadrant tenderness with a pal-
pable liver edge. There were no other masses or
organomegaly.
Haematological analyses showed a haemoglobin level of
13.9 g/dl, white cell count 10.8 × 109/l and C-reactive pro-
tein 19 mg/L. All other indices were normal as were the
plain chest and abdominal X-rays. An abdominal ultra-
sound showed a markedly abnormal liver appearance
with multiple hypoechoic lesions suggestive of multiple
metastases. The remainder of the biliary tree was normal.
A contrast-enhanced computerised tomography (CT) scan
of the chest, abdomen and pelvis confirmed multiple liver
metastases within both lobes of the liver but also a 6 × 7
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cm tumour mass in the right iliac fossa (Figures 1 &2).
There was associated lymphadenopathy extending
through the ileo-colic branch of the superior mesenteric
artery and further large lymph nodes measuring up to 1.9
cms in diameter in the aorto-caval and para-aortic regions.
Although the lesion was separate from the ileo-caecal
valve, radiological imaging suggested an appendiceal or
caecal origin. Further extrinsic pressure to the distal third
of the right ureter was present with mild hydronephrosis.
No lung parenchymal abnormality was identified.
Gastrointestinal investigation with colonoscopy was
planned but cancelled due to deteriorating symptomatol-
ogy with conservative treatment. Laparotomy revealed a
large tumour mass which appeared to originate from the
ascending colon. This was adherent to but not invading
the right ureter and lateral abdominal wall. Liver metas-
tases and multiple enlarged lymph nodes along the ileo-
colic branch of the superior mesenteric artery were also
identified. Due to the involvement of surrounding struc-
tures and a suspected caecal origin a right hemicolectomy
was performed with a primary ileo-colic anastomosis. The
right ureter was preserved as the tumour was dissected free
of both the ureter and lateral abdominal wall. No syn-
chronous colorectal tumour was identified during surgery.
Macroscopic examination showed that the tumour had
replaced the appendix without caecal involvement (Figure
3). Histological examination showed a small cell carci-
noma tumour composed of small cells with round to
ovoid nuclei, dispersed chromatin, scanty cytoplasm and
abundant mitoses (Figure 4). The tumour had extended
through the peritoneum and involved the surrounding
adipose tissue replacing the entire appendiceal mucosa.
There was extensive lymphovascular invasion and meta-
static involvement of regional lymph nodes. Immunohis-
tochemistry demonstrated positivity for the epithelial
markers CAM 5.2 and AE1/AE3 and the neuroendocrine
markers PGP 9.5, synaptophysin and TTF1. Ki-67 staining
index was approximately 90%. Tumours cells were nega-
tive for cytokeratin 7, cytokeratin 20, CD 45 (LCA),
desmin, WT-1, CD 56, chromogranin and CD 99. The
morphology and immunohistochemical features were in
Macroscopic image demonstrating the extrapulmonary small  cell carcinoma which had surrounded and replaced the  appendix without caecal involvement Figure 3
Macroscopic image demonstrating the extrapulmonary small 
cell carcinoma which had surrounded and replaced the 
appendix without caecal involvement.
Contrast-enhanced computerised tomography scan of the  abdomen demonstrating multiple liver metastases Figure 2
Contrast-enhanced computerised tomography scan of the 
abdomen demonstrating multiple liver metastases.
Contrast-enhanced computerised tomography scan of the  abdomen demonstrating a 6 cm × 7 cm tumour mass in the  right iliac fossa (white arrow) Figure 1
Contrast-enhanced computerised tomography scan of the 
abdomen demonstrating a 6 cm × 7 cm tumour mass in the 
right iliac fossa (white arrow). Although the tumour mass 
was inseparable from the lower pole of the caecum, it 
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keeping with a neuroendocrine carcinoma of small cell
type. In the absence of an identified pulmonary tumour, a
diagnosis of primary appendiceal small cell carcinoma
was made.
She made an uneventful surgical recovery and was trans-
ferred to the oncology department 12-days after surgery
for palliative chemotherapy. The patient developed a right
flank abscess after receiving one cycle of carboplatin. The
abscess was drained percutaneously. Subsequently the
patient was referred to the palliative care team and passed
away 2-months after surgery. A post mortem was not per-
formed.
Discussion
Undifferentiated small cell carcinoma (SCC) is an aggres-
sive lung tumour accounting for 15% of all lung cancers
[1]. Extrapulmonary small cell carcinomas (ESC) in com-
parison are rare with an incidence between 0.1–0.4% of
all cancers [2]. Approximately 2.5% of all SCC's arise in
extrapulmonary sites such as the salivary glands, pharynx,
larynx, nasal sinuses, pancreas, oesophagus, colon, rec-
tum, skin and cervix [2-5]. Colorectal ESCs are rare with
an incidence of 0.3% of all colorectal cancers and like SCC
of the lung, are aggressive malignancies with early metas-
tasis and have an overall 5-year survival of 13% [6]. Kim
et al (2004) reported a 12.5% incidence of colorectal ESC
with 3 patients affected from a retrospective review of 24
patients with ESC [7].
Age and sex distribution for ESC are similar to that seen in
adenocarcinoma of the colon [6]. Although smoking is
clearly implicated in the formation of pulmonary SCC, its
association with ESC is not clearly documented. This
patient was a non-smoker but there was a family history
of lung cancer with an elderly brother who died in his fif-
ties. The type of lung cancer affecting the patient's brother
was not determined and therefore it is unclear whether
her family history of lung cancer had a causative role
either.
SCC is thought to originate from neuroendocrine cells,
which are found in the epithelium of many mucosal sur-
faces including the gastrointestinal tract [6]. Despite evi-
dence of neuroendocrine involvement, the origin of ESC
is still unclear as development from undifferentiated air-
way epithelium has also been suggested along with the
amine precursor uptake and decarboxylation (APUD) sys-
tem hypothesis which proposes a common ancestral cell
derived from the neural crest, which then migrates to var-
ious epithelial tissues and sites within the body [8,9].
Histopathological diagnosis can be confirmed by the clas-
sic appearance of small round to oval shaped cells with a
finely granular and hyperchromatic nucleus, inconspicu-
ous nucleoli and scanty cytoplasm on light microscopy
[8]. SCC's show a strong and diffuse immunoreactivity for
CD 56 and 80% positivity for TTF-1 tumour markers
[10,11]. TTF-1 is positive in most cases of pulmonary
small cell carcinoma, but also shows positive staining
with many high-grade neuroendocrine carcinomas of
non-pulmonary origin. The importance of TTF-1 is to
exclude metastatic Merkel cell carcinoma, which is TTF-1
negative [11]. Due to the extent of disease in our case it
was not possible to assess dysplastic changes of the sur-
rounding mucosa. In the absence of a lung primary com-
bined with the immunohistochemical profile of the
appendiceal tumour suggests that this patient had a pure
extrapulmonary SCC of her appendix. Although carcinoid
tumours account for 32–35% of all appendiceal neo-
plasms, SCC's of the appendix are rarer with only one pre-
viously reported case by Rossi et al and this was mixed
with adenocarcinoma [12-14]. To the authors' knowledge
this is the first reported case of a pure small cell carcinoma
of the appendix. Further investigative modalities with CT
imaging and bronchoscopy are mandatory to exclude a
pulmonary origin [2]. Although this patient had a positive
family of pulmonary neoplasia, she was a non-smoker
with no respiratory symptomatology and had a normal
chest CT scan. Following consultation with the respiratory
department following surgery, no further investigation
was requested as oncological treatment was the priority.
Unfortunately clinical presentation of ESC carcinoma is
usually at an advanced stage due to the aggressive nature
of the disease. Therapeutic modalities are determined by
the location and extent of disease. Chemotherapy remains
the treatment of choice. The role of radiotherapy and sur-
High-power microscopic view of the small cell carcinoma  showing hyperchromatic nuclei, nuclear moulding and clump- ing of the nuclear chromatin Figure 4
High-power microscopic view of the small cell carcinoma 
showing hyperchromatic nuclei, nuclear moulding and clump-
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gical intervention remain limited, with surgery often only
being used for the treatment of localised disease [15].
Combination chemotherapy regimens using cisplatin-
etoposide are the most commonly used with response
rates of up to 70% [4]. There are no definite chemothera-
peutic regimens for ESC of the colon due to the small
patient numbers and clinically advanced disease at pres-
entation.
The prognosis for ESC is similar to pulmonary SCC's and
remains poor with a rapidly deteriorating clinical course.
Five-year survival is less than 13% [15]. The mean survival
for gastrointestinal ESC is less than 5-months with a 3-
and 8-month mean survival for extensive and localised
disease respectively [16].
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